Anti-EBNA2 antibody [PE2] (ab90543)
Key features and details
- Mouse monoclonal [PE2] to EBNA2
- Suitable for: WB, IP, IHC-Fr, ICC/IF
- Reacts with: Species independent
- Isotype: IgG1
Overview
-
Product name
Anti-EBNA2 antibody [PE2]
See all EBNA2 primary antibodies -
Description
Mouse monoclonal [PE2] to EBNA2 -
Host species
Mouse -
Tested applications
Suitable for: WB, IP, IHC-Fr, ICC/IFmore details -
Species reactivity
Reacts with: Species independent -
Immunogen
Recombinant fusion protein against EBNA2.
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles. -
Storage buffer
Preservative: 0.02% Sodium azide
Constituent: PBS -
Concentration information loading...
-
Purity
Protein A/G purified -
Clonality
Monoclonal -
Clone number
PE2 -
Myeloma
x63-Ag8.653 -
Isotype
IgG1 -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab90543 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
Use at an assay dependent concentration. Predicted molecular weight: 53 kDa.
|
|
IP |
Use at an assay dependent concentration.
|
|
IHC-Fr |
Use at an assay dependent concentration.
|
|
ICC/IF |
Use at an assay dependent concentration.
|
Notes |
---|
WB
Use at an assay dependent concentration. Predicted molecular weight: 53 kDa. |
IP
Use at an assay dependent concentration. |
IHC-Fr
Use at an assay dependent concentration. |
ICC/IF
Use at an assay dependent concentration. |
Target
-
Relevance
The Epstein-Barr Virus (EBV), also called Human herpesvirus 4 (HHV-4), is a virus of the herpes family and is one of the most common viruses in humans. EBNA2 is one of the few genes of Epstein-Barr virus which are necessary for immortalization of human primary B lymphocytes. The EBNA2 protein acts as a transcriptional activator of several viral and cellular genes. -
Cellular localization
Nuclear matrix of host cells -
Alternative names
- EBNA2 antibody
- EBV antibody
- EBV nuclear antigen 2 antibody
see all
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (26)
ab90543 has been referenced in 26 publications.
- Yu F et al. Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma. Front Oncol 11:626659 (2021). PubMed: 33898307
- Caduff N et al. Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLoS Pathog 16:e1008477 (2020). PubMed: 32251475
- McHugh D et al. EBV renders B cells susceptible to HIV-1 in humanized mice. Life Sci Alliance 3:N/A (2020). PubMed: 32576602
- Chizhikov D et al. Effects of Phosphatidylserine Source of Docosahexaenoic Acid on Cerebellar Development in Preterm Pigs. Brain Sci 10:N/A (2020). PubMed: 32718081
- Chatterjee B et al. CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo. PLoS Pathog 15:e1007748 (2019). PubMed: 31145756